Zdrowie i gospodarka · 25/02/1999

FDA Amends Endocrinologic and Metabolic Drugs Advisory Committee Meeting Notice

The US Food and Drug Administration (FDA) is updating the meeting details of the Endocrinologic and Metabolic Drugs Advisory Committee, originally scheduled for March 26, 1999, following a change in the agenda of the meeting notice, as announced in the Federal Register on February 8, 1999 (64 FR 6100).